Loading...
Loading...
Contributors:
Dataset URI:
10.5281/zenodo.23071119v3.0.1 Correction Changelog: Restored APC_splice_manifest-09-26-2026.json, AR_splice_manifest-09-26-2026.json so that every file referenced by the MANIFEST is present in this record. No scientific content was changed.Dataset Title: Refined Coordinate Structures and Pocket Analyses for Oncology Targets (v3.0)Overview: Fully quality-controlled 3D structural models, geometric pocket analyses, DiffDock docking enrichment, and NIH NCBI cross-validated target records for 12 therapeutic targets in this disease area: APC, AR, KRAS, ESR1, FGFR3, IDH1, JAK2, CTNNB1, CDH1, CD19, CD20, HGF. This dataset is designed for direct use in structure-based drug design campaigns by academic and industrial research groups.What's New in v3.0 (Quality Changelog): (1) 100% of structures now pass the strict steric-clash quality gate (zero non-bonded heavy-atom pairs < 1.10 Å, verified by independent reload with missing-atom completion); (2) 1 large/complex target(s) in this collection were repaired via convergent KD-tree localized clash-cluster repair and staged OpenMM minimization, and their pocket/docking analyses recomputed on the clean geometry; (3) an NCBI Entrez biological validation layer was added for every target; (4) a machine-readable manifest (CSV+JSON) with per-file MD5 checksums and per-target QC metrics was added; (5) standard file naming and engine-version provenance throughout.Included Targets:TargetNCBI Gene IDIndicationStructureClashes (<1.1 Å)Min dist (Å)Validated pocketsDocked compoundsTop reference compoundNCBI statusAPC324Colorectal cancer (tumor suppressor)repaired (localized clash repair)0>1.10 (no pairs)72SucrosevalidatedAR367Prostate cancer (androgen receptor)refined0>1.10 (no pairs)52CaffeinevalidatedKRAS3845Pancreatic/colorectal/lung cancerrefined0>1.10 (no pairs)12CaffeinevalidatedESR12099Estrogen receptor-positive breast cancerrefined0>1.10 (no pairs)42CaffeinevalidatedFGFR32261Urothelial and skeletal cancersrefined0>1.10 (no pairs)52CaffeinevalidatedIDH13417Glioma and AML (metabolic mutant enzyme)refined0>1.10 (no pairs)32CaffeinevalidatedJAK23717Myeloproliferative neoplasmsrefined0>1.10 (no pairs)82CaffeinevalidatedCTNNB11499Wnt-driven cancers (beta-catenin)refined0>1.10 (no pairs)42CaffeinevalidatedCDH1999Gastric and lobular breast cancer (E-cadherin)refined0>1.10 (no pairs)42CaffeinevalidatedCD19930B-cell malignancies (CAR-T target)refined0>1.10 (no pairs)22CaffeinevalidatedCD20931B-cell lymphomas (rituximab target)refined0>1.10 (no pairs)32CaffeinevalidatedHGF3569Cancer metastasis and tissue repairrefined0>1.10 (no pairs)32CaffeinevalidatedComputational Methodology: (1) Structure prediction with the Boltz-2 deep-learning co-folding engine (NVIDIA NIM API); (2) physics refinement with OpenMM (Amber14-all force field, OBC2 implicit solvent, C-alpha harmonic guide restraints k_guide = 0.5, GPU/OpenCL); (3) for outlier targets: ultra-stable staged recovery (convergent KD-tree surgical pre-cleaning + cold→stabilizing→gold minimization) and localized Jacobi-style clash-cluster repair with rigid bonded-hydrogen movement, disulfide-aware (CYS→CYX) processing, and reload verification; (4) LIGSITE-style protein-solvent-protein pocket detection (0.9 Å grid, PSP ≥ 3) with geometric druggability gates (volume 120–2500 ų, ≥ 10 lining residues); (5) DiffDock (NVIDIA NIM API) docking enrichment with reference active compounds and decoy probes — higher (less negative) confidence scores indicate more reliable poses; (6) NCBI Entrez biological validation cross-referencing every target against curated NIH records.Quality Control: Clash gate definition: zero non-bonded heavy-atom pairs closer than 1.10 Å (bonded and sequence-adjacent residues excluded), measured after independent structure reload with missing-atom completion. All 12 targets in this collection pass. Aggregate: 49 validated pockets, 24 compound-target docking results, 12/12 targets with curated NCBI records.Data Contents: per target: refined coordinate structure (PDB with hydrogens), structure QC report, geometric pocket analysis (JSON), docking enrichment results (JSON), toxicology profile report (TPR, where available), consensus toxicology (JSON, where available), ClinVar variant-to-pocket map (JSON, where available), splice/chain provenance manifest (where applicable); dataset level: machine-readable MANIFEST (CSV+JSON, per-file MD5 + per-target QC), NCBI bio-validation layer (JSON), and README with methodology.Usage Notes: PDB files load directly into Schrödinger, MOE, Discovery Studio, PyMOL, ChimeraX and RDKit/OpenBabel pipelines (standard PDB format with hydrogens). Pocket residue lists in the JSON analyses use the structure's internal residue indexing (0-based); map to your numbering via the companion structure files. Docking confidence values are DiffDock confidence scores (higher is better).Important Caveat: All structures and analyses are computational predictions. They are suitable for hypothesis generation, lead discovery and campaign prioritization, and require experimental validation before clinical or therapeutic use.FAIR Compliance: F1–F4 (persistent DOI, rich machine-readable metadata, indexed in the nexus-resonance-codex community); A1–A2 (open access over HTTPS, metadata persistence via versioned records); I1–I3 (standard PDB/JSON/CSV formats, HGNC/NCBI vocabularies, qualified cross-references); R1–R1.3 (rich QC attributes, CC BY 4.0 commercial-use license, full provenance, domain standards).Integrity & Provenance: Every file in this dataset carries an MD5 checksum recorded in the machine-readable MANIFEST (CSV+JSON). Engine versions and generation dates are embedded in file names and companion QC reports. TTT-7 audit flags are organizational conventions only.License: Creative Commons Attribution 4.0 International (CC BY 4.0) — open for academic and commercial therapeutic drug design.Principal Investigator: James Paul TrageserAffiliation: Nexus Resonance CodexORCID: 0009-0006-6678-2908X (Twitter): @jtragOrganization: https://github.com/Nexus-Resonance-Codex
Keyword(s):
Amber14; APC; AR; biophysical audits; Boltz-2.
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)